ArticleRheumatology (Oxford, England)2025

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement.

Olof C B Vermeulen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.